J&J Rides Standalone Consumer Health Track
J&J takes same approach GSK, Pfizer, Merck & Co, Merck and Novartis have with their consumer health businesses, Bausch Health is starting and Sanofi says it will.
You may also be interested in...
AESGP Annual Meeting, Day 2 (Part 1): The Future For Europe’s Self-Care Industry Is Bright And Digital
Day 2 of the AESGP’s 58th Annual Meeting in Madrid, Spain begins with optimism about the future of the European self-care industry. Google and IQVIA Consumer Health analyze COVID-19 trends to help industry prepare for the post-pandemic new normal, while Convert Group and Swedish e-pharmacy Meds.se emphasize the opportunity presented by e-commerce for consumer health.
Heiko Schipper, Global Self-Care Federation chairman and Bayer’s consumer health business head, says for some consumers, “it’s this or nothing.” Federation study found between $100bn and $200bn is saved annually worldwide from consumers spending on self-care rather than medical care.
Pharma R&D VP Mathai Mammen acknowledges “pros and cons to remaining” as one company but dismissed “any meaningful downside” for the pharma business, which along with the device business will continue operating as J&J.